Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life.

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Duchenne Muscular Dystrophy
Trial Locations (1)

0424

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

The Research Council of Norway

OTHER

collaborator

University Hospital of North Norway

OTHER

lead

Oslo University Hospital

OTHER

NCT01963897 - Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life. | Biotech Hunter | Biotech Hunter